RWC Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by RWC Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by RWC Asset Management from 13F filings

Historical chart of RWC Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by RWC Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by RWC Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.8M 4.0M 1.19
2024-06-30 $4.4M 4.0M 1.11
2024-03-31 $3.9M 4.0M 0.97
2023-12-31 $4.9M 5.3M 0.93
2023-09-30 $5.0M 5.3M 0.94